splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants

Familial Parkinson’s disease (PD) is associated with duplication or mutations of α-synuclein gene, whose product is a presynaptic cytosolic protein also found in mitochondria and in mitochondrial-associated ER membranes. We have originally shown the role of α-syn as a mod...

Full description

Bibliographic Details
Main Authors: Tito Calì, Denis Ottolini, Mattia Vicario, Cristina Catoni, Francesca Vallese, Domenico Cieri, Lucia Barazzuol, Marisa Brini
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/8/9/1072
id doaj-49f562495f8c46f4bb2b4a96eda9f7e6
record_format Article
spelling doaj-49f562495f8c46f4bb2b4a96eda9f7e62020-11-25T02:03:26ZengMDPI AGCells2073-44092019-09-0189107210.3390/cells8091072cells8091072splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P MutantsTito Calì0Denis Ottolini1Mattia Vicario2Cristina Catoni3Francesca Vallese4Domenico Cieri5Lucia Barazzuol6Marisa Brini7Department of Biomedical Sciences, University of Padova, Padova 35131, ItalyDepartment of Biology, University of Padova, Padova 35131, ItalyDepartment of Biomedical Sciences, University of Padova, Padova 35131, ItalyDepartment of Biology, University of Padova, Padova 35131, ItalyDepartment of Biomedical Sciences, University of Padova, Padova 35131, ItalyDepartment of Biomedical Sciences, University of Padova, Padova 35131, ItalyDepartment of Biomedical Sciences, University of Padova, Padova 35131, ItalyDepartment of Biology, University of Padova, Padova 35131, ItalyFamilial Parkinson&#8217;s disease (PD) is associated with duplication or mutations of &#945;-synuclein gene, whose product is a presynaptic cytosolic protein also found in mitochondria and in mitochondrial-associated ER membranes. We have originally shown the role of &#945;-syn as a modulator of the ER-mitochondria interface and mitochondrial Ca<sup>2+</sup> transients, suggesting that, at mild levels of expression, &#945;-syn sustains cell metabolism. Here, we investigated the possibility that &#945;-syn action on ER-mitochondria tethering could be compromised by the presence of PD-related mutations. The clarification of this aspect could contribute to elucidate key mechanisms underlying PD. The findings reported so far are not consistent, possibly because of the different methods used to evaluate ER-mitochondria connectivity. Here, the effects of the PD-related &#945;-syn mutations A53T and A30P on ER-mitochondria relationship were investigated in respect to Ca<sup>2+</sup> handling and mitochondrial function using a newly generated SPLICS sensor and aequorin-based Ca<sup>2+</sup>measurements. We provided evidence that A53T and A30P amino acid substitution does not affect the ability of &#945;-syn to enhance ER/mitochondria tethering and mitochondrial Ca<sup>2+</sup> transients, but that this action was lost as soon as a high amount of TAT-delivered A53T and A30P &#945;-syn mutants caused the redistribution of &#945;-syn from cytoplasm to foci. Our results suggest a loss of function mechanism and highlight a possible connection between &#945;-syn and ER-mitochondria Ca<sup>2+</sup> cross-talk impairment to the pathogenesis of PD.https://www.mdpi.com/2073-4409/8/9/1072Parkinson’s diseasealpha-synucleincalciummitochondriaER-mitochondria contact sites
collection DOAJ
language English
format Article
sources DOAJ
author Tito Calì
Denis Ottolini
Mattia Vicario
Cristina Catoni
Francesca Vallese
Domenico Cieri
Lucia Barazzuol
Marisa Brini
spellingShingle Tito Calì
Denis Ottolini
Mattia Vicario
Cristina Catoni
Francesca Vallese
Domenico Cieri
Lucia Barazzuol
Marisa Brini
splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
Cells
Parkinson’s disease
alpha-synuclein
calcium
mitochondria
ER-mitochondria contact sites
author_facet Tito Calì
Denis Ottolini
Mattia Vicario
Cristina Catoni
Francesca Vallese
Domenico Cieri
Lucia Barazzuol
Marisa Brini
author_sort Tito Calì
title splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
title_short splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
title_full splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
title_fullStr splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
title_full_unstemmed splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
title_sort splitgfp technology reveals dose-dependent er-mitochondria interface modulation by α-synuclein a53t and a30p mutants
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2019-09-01
description Familial Parkinson&#8217;s disease (PD) is associated with duplication or mutations of &#945;-synuclein gene, whose product is a presynaptic cytosolic protein also found in mitochondria and in mitochondrial-associated ER membranes. We have originally shown the role of &#945;-syn as a modulator of the ER-mitochondria interface and mitochondrial Ca<sup>2+</sup> transients, suggesting that, at mild levels of expression, &#945;-syn sustains cell metabolism. Here, we investigated the possibility that &#945;-syn action on ER-mitochondria tethering could be compromised by the presence of PD-related mutations. The clarification of this aspect could contribute to elucidate key mechanisms underlying PD. The findings reported so far are not consistent, possibly because of the different methods used to evaluate ER-mitochondria connectivity. Here, the effects of the PD-related &#945;-syn mutations A53T and A30P on ER-mitochondria relationship were investigated in respect to Ca<sup>2+</sup> handling and mitochondrial function using a newly generated SPLICS sensor and aequorin-based Ca<sup>2+</sup>measurements. We provided evidence that A53T and A30P amino acid substitution does not affect the ability of &#945;-syn to enhance ER/mitochondria tethering and mitochondrial Ca<sup>2+</sup> transients, but that this action was lost as soon as a high amount of TAT-delivered A53T and A30P &#945;-syn mutants caused the redistribution of &#945;-syn from cytoplasm to foci. Our results suggest a loss of function mechanism and highlight a possible connection between &#945;-syn and ER-mitochondria Ca<sup>2+</sup> cross-talk impairment to the pathogenesis of PD.
topic Parkinson’s disease
alpha-synuclein
calcium
mitochondria
ER-mitochondria contact sites
url https://www.mdpi.com/2073-4409/8/9/1072
work_keys_str_mv AT titocali splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT denisottolini splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT mattiavicario splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT cristinacatoni splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT francescavallese splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT domenicocieri splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT luciabarazzuol splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
AT marisabrini splitgfptechnologyrevealsdosedependentermitochondriainterfacemodulationbyasynucleina53tanda30pmutants
_version_ 1724948239803744256